Forcyte Biotechnologies, Inc

the function-first biology company

PARTNER WITH US

Your technology partner for understanding mechanomics

We have a

platform advantage

Our FLECS platform gives us the unique ability look at what matters-

cell function

- early and at scale
This gives us a data advantage

We’re building the world’s largest data repository of mechanical cell function

This proprietary and differentiated dataset unlocks:

Biology

New target discovery directly linked to cell function

circarrow

Chemistry

New therapeutics modifying mechanomic processes

Translation

Improved predictive models to support clinical success

Primary
human
cells

This proprietary and differentiated dataset unlocks:

Biology

New target discovery directly linked to cell function

Chemistry

New therapeutics modifying mechanomic processes

Translation

New therapeutics modifying mechanomic processes

PARTNER WITH US

Unlocking human mechanobiology together to drive patient impact

Better Biology

Discover new targets driving contractility

We run arrayed gene-silencing screens with functional cell contractility as the direct readout at the whole-genome scale, empirically linking gene to mechanical cell function for the first time across a multitude of cell types.

Better Chemstry

Screen libraries for force-modulating hits

We rapidly screen large drug libraries at throughputs of up to >18,000 wells per day each reporting functional contractility data from 100s of single-cells to identify molecular modulators of the contractile phenotype.

Better Translation

Access functional readouts in mechanobiology

We place function first, building assay models for all contractile cells in the human body using primary human material to provide rapid and cost-effective functional efficacy data in vitro to help prioritize programs for our partners.

Get in touch

Let's unlock mechanomics to advance your pipeline

Learn more about how our platform enables
better biology, better chemistry & better translation
Scroll to Top